ClinicalTrials.Veeva

Menu

Prevention of Liver Damage During Liver Surgery (LTR)

L

Ludwig Maximilian University of Munich

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Liver Tumors

Treatments

Drug: adenosine
Procedure: Liver resection
Drug: placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT00845689
LMU-202-LTR

Details and patient eligibility

About

Liver damage as a consequnce of ischemia (I) and reperfusion (R) is known to harm the liver and could hence be a critical factor of the postoperative outcome of patients undergoing liver surgery. In order to protect the liver from ischemic damage following interventions such as the Pringle Maneuver, preconditioning has been successfully applied in various animal models as well as in humans. Since ischemia inevitably leads to cell hypoxia and subsequnet release of endogenuous metabolites, the investigators hypothesize that instead of brief periods of ischemia, the exogenuous infusion of purine analogues may also protect against subsequent prolonged periods of ischemia. Moreover, after reperfusion, the antiinflamamtory action of purine ananlogue infusion can further attenuated liver damage.

Sex

Volunteers

No Healthy Volunteers

Inclusion criteria

  • elective resection of liver tumors
  • age 18 to 80 years
  • informed consent

Exclusion criteria

  • chronic obstructive pulmonary disease
  • heart insufficiency NYHA III-IV
  • atrio-ventricular conductance blockage II. (Mobitz) or III. degree
  • atrial fibrillation
  • coronary heart disease (CCS III. or IV. degree)
  • arterial hypertension
  • acute renal failure
  • increased intracranial pressure
  • gout
  • pregnancy

Trial design

0 participants in 3 patient groups, including a placebo group

1
Placebo Comparator group
Description:
liver resection with Pringle + placebo
Treatment:
Drug: placebo
Procedure: Liver resection
2
Active Comparator group
Description:
liver resection with Pringle + adenosine preconditiong
Treatment:
Drug: adenosine
Drug: adenosine
Procedure: Liver resection
3
Active Comparator group
Description:
liver resection with Pringle + adenosine pre- and postconditioning
Treatment:
Drug: adenosine
Drug: adenosine
Procedure: Liver resection

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems